Next report date
Report period
Q1 2024
EPS estimate
−0.04USD
Revenue estimate
—
−5.30 MUSD
14.86 M
Om Virios Therapeutics, Inc.
Sektor
Bransch
VD
Gregory Duncan
Webbplats
Huvudkvarter
Alpharetta
Employees (FY)
4
Grundat
2012
FIGI
BBG00X0SZKJ2
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
